Investors in Iot

We support new entrepreneurs and develop new business models by sharing our professional network and our wealth of know-how to create long-term value and positive social impact on the territories.Ulixes Sgr wants to contribute to the resolution of structural problems, even in traditional sectors, paying attention to international macro trends of technological and socio-economic development, in compliance with the sustainable development goals (SDGs) promoted by the United Nations in the 2030 Agenda.

Rialto is focused on supporting European founders operating in hard tech sectors which demonstrates domain expertise in recession-proof strategic verticals, such as developer tools, robotics, non-gen AI, cybersecurity, AR/VR, Enterprise SaaS, tech-enabled healthcare, and cloud services.

Since 2015, the company has focused on investing in startups and innovative companies to generate value, particularly in the tourism and leisure sectors, digital marketing, fintech, and science. They provide comprehensive support to startups through advisory services, leveraging their extensive entrepreneurial experience. Their offerings include designing and managing entrepreneurship training courses, providing strategic advice, evaluating and reviewing business plans, structuring value propositions and business development, supporting business organization and team building, mentoring, developing fundraising strategies, and offering guidance on legal aspects.

Padda health is a VALUE CREATOR VENTURE CAPITAL that invests in innovative start-ups and SMEs in the healthcare area, sustaining them with a value generating skills network, through Padda Innovation Town. Padda health possesses a vision of open innovation on a global scale, while featuring the relationships usually connected with a family office. Padda health moves quickly, creating and providing value, turning start-ups into great game changers through something worth much more than money, i.e. human capital. Padda health is a start-up enabler that, by making use of a network of professionals in the fields of marketing, HR, procurement, legal and finance, aims to support the key areas during all the development stages of the start-ups

Giano Ventures is a VC investor in the most promising technology startups in Italy and five other European markets (Germany, France, Poland, Spain, Switzerland). It focuses on building, managing, and improving early-stage companies. Its portfolio companies achieve fast growth trajectories and early profitability and they are a hands-on investor who works alongside the management teams of portfolio companies bringing tangible value-added. Its extensive network of connections ranging from entrepreneurs and SMEs to corporates, institutions, and investors to secure important commercial agreements for our portfolio companies.

Droia is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease. Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients. With our team of seasoned scientists, entrepreneurs and investment professionals we build great companies to save patients' lives.

UniFund aims to ignite entrepreneurship by leveraging the hidden potential within Greek universities, R&D, and tech spaces, focusing on people and team development. They invest in sectors such as ICT, fintech, health-tech, IoT, robotics, and more, providing seed funding and support to early-stage startups. UniFund's experienced team helps startups implement successful go-to-market strategies and build the foundations of the entrepreneurial ecosystem.

Start Codon focuses on translating disruptive research into successful startups, emphasizing a unique approach influenced by Cambridge's innovation ecosystem. The firm identifies promising technologies and research with commercial potential, providing seed funding, mentoring, and access to networks. Start Codon aims to accelerate the development of early-stage biotech and healthcare startups, contributing to breakthrough innovations in these fields. Through its tailored support and strategic guidance, Start Codon plays a crucial role in bridging the gap between scientific discovery and market-ready solutions.

They invest in entrepreneurs and innovations, always prioritizing people who generate ideas and create new realities. They are committed to industries they believe are both innovative and sustainable in the long term, including Bio-Tech, Green-Tech, Health-Tech, Fin-Tech, Deep-Tech, New Space, and Smart Urban Development. Their investments span across Europe and the US.

Candy Capital is a privately-held family office established by British entrepreneur and businessman Nick Candy. As a family office, Candy Capital likely manages investments and assets on behalf of the Candy family, focusing on a diverse range of investment opportunities. Their investment strategy may include direct investments, private equity, venture capital, real estate, and other asset classes. Candy Capital's approach is likely driven by long-term wealth preservation and growth, leveraging their founder's entrepreneurial success and expertise to identify strategic investment opportunities. They may also engage in philanthropic initiatives or strategic partnerships aligned with their investment philosophy and family values.

Ambrosia Investments is an investment firm focused on providing growth capital for disruptive brands and businesses in the food, beverage and ingredients industries. Ambrosia looks to bring entrepreneurial experience and advice to its portfolio companies, while also maintaining a long-term perspective. Ambrosia is focused on minority growth capital investments in primarily Europe and the United States, with a sweet spot investment size range of €2 to €20 million per deal.

GM&C Life Sciences Fund specializes in providing venture capital funds to entrepreneurs operating in the life sciences sector. The fund focuses on supporting innovative startups and companies that are developing breakthrough technologies and solutions in areas such as biotechnology, pharmaceuticals, medical devices, and healthcare services. GM&C Life Sciences Fund aims to accelerate the growth and commercialization of promising life sciences ventures by offering strategic capital, industry expertise, and networking opportunities. The fund plays a crucial role in advancing cutting-edge research and development efforts that have the potential to transform healthcare and improve patient outcomes globally.